User profiles for "author:E Hamilton"

Emily G. Hamilton

Postdoctoral Scholar, Stanford University
Verified email at stanford.edu
Cited by 3705

[PDF][PDF] HER2-low breast cancer: pathological and clinical landscape

P Tarantino, E Hamilton, SM Tolaney… - Journal of Clinical …, 2020 - source.ymvkt.cn
Breast cancer (BC) is the most commonly diagnosed cancer in women worldwide. 1 It is a
heterogeneous disease, comprising distinct biologic entities with different prognosis and …

[HTML][HTML] Targeting HER2-positive breast cancer: advances and future directions

SM Swain, M Shastry, E Hamilton - Nature reviews Drug discovery, 2023 - nature.com
The long-sought discovery of HER2 as an actionable and highly sensitive therapeutic target
was a major breakthrough for the treatment of highly aggressive HER2-positive breast …

The substitution augmentation modification redefinition (SAMR) model: A critical review and suggestions for its use

ER Hamilton, JM Rosenberg, M Akcaoglu - TechTrends, 2016 - Springer
Abstract The Substitution, Augmentation, Modification, and Redefinition (SAMR) model is a
four-level, taxonomy-based approach for selecting, using, and evaluating technology in K-12 …

[HTML][HTML] Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled …

…, Z Gray, LB Guthrie, M Hackett, S Halwe, E Hamilton… - The Lancet, 2020 - thelancet.com
Background The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) might be curtailed by vaccination. We assessed the safety, reactogenicity, and …

[HTML][HTML] Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer

…, V Petry, CF Chung, H Iwata, E Hamilton… - … England Journal of …, 2022 - Mass Medical Soc
Background Trastuzumab emtansine is the current standard treatment for patients with
human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer whose …

An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues

MR Corces, AE Trevino, EG Hamilton, PG Greenside… - Nature …, 2017 - nature.com
We present Omni-ATAC, an improved ATAC-seq protocol for chromatin accessibility profiling
that works across multiple applications with substantial improvement of signal-to …

[HTML][HTML] Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer

…, A Okines, E Paplomata, E Hamilton… - … England Journal of …, 2020 - Mass Medical Soc
Background Patients with human epidermal growth factor receptor 2 (HER2)–positive
metastatic breast cancer who have disease progression after therapy with multiple HER2 …

[HTML][HTML] Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for …

…, T Peretz, G Fried, NB Baruch, D Katz, E Hamilton… - Annals of …, 2021 - Elsevier
Background In the phase III IMpassion130 trial, combining atezolizumab with first-line
nanoparticle albumin-bound-paclitaxel for advanced triple-negative breast cancer (aTNBC) …

Geoacoustic modeling of the sea floor

EL Hamilton - The Journal of the Acoustical Society of America, 1980 - pubs.aip.org
Geoacoustic models of the sea floor are basic to underwater acoustics and to marine
geological and geophysical studies of the earth's crust, including stratigraphy …

The ELF4–ELF3–LUX complex links the circadian clock to diurnal control of hypocotyl growth

DA Nusinow, A Helfer, EE Hamilton, JJ King… - Nature, 2011 - nature.com
The circadian clock is required for adaptive responses to daily and seasonal changes in
environmental conditions,,. Light and the circadian clock interact to consolidate the phase of …